Quantitative expression of oestrogen receptor in breast cancer: Clinical and molecular significance-Reference-Cited by-同舟云学术

Quantitative expression of oestrogen receptor in breast cancer: Clinical and molecular significance

Published:2024-01 Issue: Volume:197 Page:113473
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

Makhlouf Shorouk^ORCID,Quinn Cecily,Toss Michael,Alsaleem Mansour^ORCID,Atallah Nehal M.,Ibrahim Asmaa,Rutland Catrin S.,Mongan Nigel P.,Rakha Emad A.

Funder

Ministry of Higher Education

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference84 articles.

1. Genomic index of sensitivity to endocrine therapy for breast cancer;Symmans;J Clin Oncol,2010

2. Estrogen and progesterone receptor testing in breast cancer: ASCO/CAP guideline update;Allison;J Clin Oncol,2020

3. Low ER+ breast cancer: is this a distinct group?;Gloyeske;Am J Clin Pathol,2014

4. Relevance of breast cancer hormone receptors and other factors to the efficacy of adjuvant tamoxifen: patient-level meta-analysis of randomised trials;lancet,2011

5. Estrogen receptor (ER) mRNA and ER-related gene expression in breast cancers that are 1% to 10% ER-positive by immunohistochemistry;Iwamoto;J Clin Oncol,2012

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Reporting Hormone Receptor Expression in Breast Carcinomas: Which Method has the Highest Prognostic Power and What Should be the Optimal Cut-off Value?;International Journal of Surgical Pathology;2024-09-08

2. Comparative effectiveness analysis of survival with first-line palbociclib or ribociclib plus AI in HR + /HER2- advanced breast cancer (CEPRA study): preliminary analysis of real-world data from Thailand;BMC Cancer;2024-08-16

3. Final Results of RIGHT Choice: Ribociclib Plus Endocrine Therapy Versus Combination Chemotherapy in Premenopausal Women With Clinically Aggressive Hormone Receptor–Positive/Human Epidermal Growth Factor Receptor 2–Negative Advanced Breast Cancer;Journal of Clinical Oncology;2024-08-10